#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Narcolepsy Optic glioma Primary biliary cholangitis Aplastic anaemia PIK3CA-activated mutation Congenital pseudarthrosis Thrombocytosis Cutaneous T-cell lymphoma stage I Bile acid synthesis disorder Ovarian cancer stage III Microvillous inclusion disease Precursor T-lymphoblastic lymphoma/leukaemia recurrent Hypersomnia Epstein-Barr virus associated lymphoproliferative disorder Mantle cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Basic Information Choroid melanoma – Treatment Mucopolysaccharidosis I – Trials in Disease Haemophilia B with anti factor IX – Trials in Disease Sjogren’s syndrome – Diagnostics Pulmonary sarcoidosis – Diagnostics Marginal zone lymphoma refractory Encephalitis autoimmune – Diagnostics Niemann-Pick disease – Diagnostics Pleomorphic leiomyosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Quetiapine Balcinrenone Nacystelyn Doxazosin LIPASE Hct116-B Tramadol Hydrochloride Ramipril Fexofenadine Hydrochloride Corylus Avellana L. Laronidase Pilocarpine Hydrochloride Amitriptyline Asciminib Hydrochloride Gelatin Pirfenidone Dexrazoxane Diltiazem Topiramate Enpatoran More therapies…

    Learn about Your Condition

    Obesity Plasma cell leukaemia Arteriovenous graft thrombosis Cerebrovascular accident Pathogen resistance Obstructive airways disorder Metastasis Usher's syndrome Heart transplant Fontan procedure Chondrosarcoma Colorectal cancer stage IV Hodgkin's disease refractory Testicular germ cell cancer Oesophageal food impaction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice…

Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha

U Vojenske Nemocnice 1200, Prague, 169 02, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Vericiguat for Adults with Chronic Heart Failure with Reduced Ejection Fraction

    Not recruiting

    3 1
    Investigated Diseases:
    • Heart failure with reduced ejection fraction
    Investigated Drugs:
    • Vericiguat
    Austria Czechia Denmark France Germany Greece +6

  • Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clopidogrel
    • Milvexian
    • Acetylsalicylic Acid
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis and Portal Hypertension

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Austria Belgium Czechia Denmark France Germany +3

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Clopidogrel
    • Milvexian
    • Prasugrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Andexanet Alfa
    • Milvexian
    • Apixaban
    Belgium Bulgaria Croatia Czechia Denmark Estonia +13

  • Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

    Not recruiting

    3 1
    Investigated Drugs:
    • Obicetrapib
    Bulgaria Croatia Czechia Denmark Finland Germany +7
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!